GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy.
Department of Life Sciences, University of Siena, Siena, Italy.
Front Cell Infect Microbiol. 2022 Feb 3;12:767153. doi: 10.3389/fcimb.2022.767153. eCollection 2022.
Generalized Modules for Membrane Antigens (GMMA) are outer membrane exosomes purified from Gram-negative bacteria genetically mutated to increase blebbing and reduce risk of reactogenicity. This is commonly achieved through modification of the lipid A portion of lipopolysaccharide. GMMA faithfully resemble the bacterial outer membrane surface, and therefore represent a powerful and flexible platform for vaccine development. Although GMMA-based vaccines have been demonstrated to induce a strong and functional antibody response in animals and humans maintaining an acceptable reactogenicity profile, the overall impact on immune cells and their mode of action are still poorly understood. To characterize the GMMA-induced immune response, we stimulated human peripheral blood mononuclear cells (hPBMCs) with GMMA from . We studied GMMA both with wild-type hexa-acylated lipid A and with the corresponding less reactogenic penta-acylated form. Using multicolor flow cytometry, we assessed the activation of immune cell subsets and we profiled intracellular cytokine production after GMMA stimulation. Moreover, we measured the secretion of thirty cytokines/chemokines in the cell culture supernatants. Our data indicated activation of monocytes, dendritic, NK, B, and γδ T cells. Comparison of the cytokine responses showed that, although the two GMMA have qualitatively similar profiles, GMMA with modified penta-acylated lipid A induced a lower production of pro-inflammatory cytokines/chemokines compared to GMMA with wild-type lipid A. Intracellular cytokine staining indicated monocytes and dendritic cells as the main source of the cytokines produced. Overall, these data provide new insights into the activation of key immune cells potentially targeted by GMMA-based vaccines.
通用膜抗原模块(GMMA)是从遗传突变以增加出泡和降低反应原性风险的革兰氏阴性细菌中纯化的外膜外泌体。这通常通过修饰脂多糖的脂质 A 部分来实现。GMMA 忠实地模仿细菌外膜表面,因此代表了疫苗开发的强大而灵活的平台。尽管基于 GMMA 的疫苗已被证明在动物和人类中诱导强烈且功能性的抗体反应,同时保持可接受的反应原性特征,但对免疫细胞的总体影响及其作用方式仍知之甚少。为了表征 GMMA 诱导的免疫反应,我们用 GMMA 刺激人外周血单核细胞(hPBMC)。我们用野生型六酰化脂质 A 和相应的反应原性较低的五酰化形式研究 GMMA。通过多色流式细胞术,我们评估了免疫细胞亚群的激活,并在 GMMA 刺激后分析了细胞内细胞因子的产生情况。此外,我们测量了细胞培养上清液中三十种细胞因子/趋化因子的分泌。我们的数据表明单核细胞、树突状细胞、NK、B 和 γδ T 细胞被激活。细胞因子反应的比较表明,尽管两种 GMMA 具有定性相似的特征,但与具有野生型脂质 A 的 GMMA 相比,具有修饰的五酰化脂质 A 的 GMMA 诱导的促炎细胞因子/趋化因子产生较低。细胞内细胞因子染色表明单核细胞和树突状细胞是产生细胞因子的主要来源。总的来说,这些数据为 GMMA 基于疫苗潜在靶向的关键免疫细胞的激活提供了新的见解。